Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Generium Pharmaceuticals (Russia)
Homepage:
generium.ru
Alternate names:
Generium Pharmaceuticals,
IBC Generium,
JSC Generium,
АО «ГЕНЕРИУМ»,
Генериум
ROR:
04anvdv29
OpenAlex ID:
I4405272539
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
2018
·
Frédéric Lessard
, Sebastian Igelmann
, et al.
·
Nature Cell Biology
·
180
Targeting the Wnt pathways for therapies
2014
·
Artem Blagodatski
, Dmitry Poteryaev
, et al.
·
Molecular and Cellular Therapies
·
149
Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients
2013
·
Petr Dmitriev
, Luiza Stankevicins
, et al.
·
Journal of Biological Chemistry
·
81
PDF
Novel strong promoter of antimicrobial peptides gene pro-SmAMP2 from chickweed (Stellaria media)
2016
·
Roman A. Komakhin
, Denis A. Vysotskii
, et al.
·
BMC Biotechnology
·
63
PDF
Stimulation of Sigma Receptors with Afobazole Blocks Activation of Microglia and Reduces Toxicity Caused by Amyloid-β25–35
2013
·
Adam A. Behensky
, Ilya E. Yasny
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
50
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
2021
·
Irina Leneva
, Nadezhda Kartashova
, et al.
·
Viruses
·
47
PDF
The Krüppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy
2011
·
Petr Dmitriev
, Andrei Petrov
, et al.
·
Journal of Biological Chemistry
·
43
PDF
Afobazole Activation of σ-1 Receptors Modulates Neuronal Responses to Amyloid-β25–35
2013
·
Adam A. Behensky
, Ilya E. Yasny
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
42
Shambhala: a platform-agnostic data harmonizer for gene expression data
2019
·
Nicolas Borisov
, Irina Shabalina
, et al.
·
BMC Bioinformatics
·
41
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100))
2021
·
Elena L. Amelina
, Stanislav A. Krasovsky
, et al.
·
PLoS ONE
·
36
Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy
2020
·
V. V. Ptushkin
, A. D. Kulagin
, et al.
·
Terapevticheskii arkhiv
·
36
PDF
PASylation technology improves recombinant interferon-β1b solubility, stability, and biological activity
2016
·
Elizaveta A. Zvonova
, Alexander V. Ershov
, et al.
·
Applied Microbiology and Biotechnology
·
34
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab
2021
·
Alexander D. Kulagin
, Vadim V. Ptushkin
, et al.
·
Annals of Hematology
·
33
PDF
Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes
2013
·
C. Katnik
, A. Garcia
, et al.
·
Neurobiology of Disease
·
31
Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data
2019
·
Aleksandr Kulagin
, Vadim Ptushkin
, et al.
·
Blood
·
29
COVID-19 Vaccines: An Updated Overview of Different Platforms
2022
·
Dmitry Kudlay
, Andrey Svistunov
, et al.
·
Bioengineering
·
26
PDF
Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke
2016
·
Christopher Katnik
, Angela Garcia
, et al.
·
Journal of Neurochemistry
·
25
Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children
2015
·
L. Slogotskaya
, E. Bogorodskaya
, et al.
·
European Respiratory Journal
·
25
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
2013
·
Ludmila Slogotskaya
, Elena Bogorodskaya
, et al.
·
European Respiratory Journal
·
24
Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from Rhodospirillum rubrum to Inhibit Telomerase
2020
·
Anna Plyasova
, Marina Pokrovskaya
, et al.
·
Pharmaceuticals
·
20
PDF
Analytical and functional similarity of biosimilar Elizaria® with eculizumab reference product
2022
·
Valentina Gusarova
, Maxim Degterev
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
18
The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndrome
2020
·
Yulia V. Lavrishcheva
, Alexander A. Yakovenko
, et al.
·
Terapevticheskii arkhiv
·
17
PDF
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016
·
Casey Ager
, Matthew Reilley
, et al.
·
Journal for ImmunoTherapy of Cancer
·
17
PDF
Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit
2021
·
D. A. Poteryaev
, S. G. Abbasova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
15
PDF
Tuberculosis in the Russian Federation: Prognosis and Epidemiological Models in a Situation After the COVID-19 Pandemic
2023
·
Anna Starshinova
, Ekaterina Belyaeva
, et al.
·
Journal of Epidemiology and Global Health
·
13
PDF
Show more works
View as search
Works count:
177
Citation count:
3,277
Year
Topic
Type
